Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-16

Clinical Trial Update: A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing an investigational drug to an approved treatment for Parkinson's disease with motor OFF episodes; study status completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Approved drug used to treat Parkinson's disease with OFF episodes

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Motor OFF Episodes Associated With Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-12-16